Related Experiment Video
Updated: Jun 6, 2026
07:34
Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve
Published on: August 5, 2021
Mitral valve re-replacement in a patient with osteogenesis imperfecta
B Pfannmueller1, M A Borger, R R Battellini
1Heart Surgery, Heart Centre Leipzig, Leipzig, Germany. bettina.pfannmueller@med.uni-leipzig.de
The Thoracic and Cardiovascular Surgeon
|November 27, 2010
Summary
Patients with osteogenesis imperfecta (OI) can benefit from minimally invasive valve surgery. This approach preserves thorax stability during initial valve replacement and subsequent reoperations.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Thoracic Surgery
Background:
- Osteogenesis imperfecta (OI) presents unique challenges for cardiac surgery due to bone fragility.
- Minimally invasive cardiac surgery (MICS) is often considered to minimize trauma in these patients.
- Bioprosthetic valves were initially chosen for a patient with OI due to concerns about mechanical valve thrombosis and injury.
Observation:
- A 34-year-old patient with OI underwent double-valve replacement (aortic and mitral).
- Five years post-implantation, the patient required re-replacement of a stenotic mitral bioprosthesis.
- Both the initial surgery and the mitral valve reoperation were performed using a right anterolateral mini-thoracotomy.
Findings:
- Minimally invasive right anterolateral mini-thoracotomy provided adequate access for both primary double-valve replacement and subsequent mitral valve reoperation in a patient with OI.
- The surgical approach prioritized thoracic stability, a critical consideration in patients with OI.
- Successful reoperation was achieved without apparent complications related to bone fragility.
Implications:
- Minimally invasive valve surgery, including reoperations, is a viable and potentially beneficial option for patients with osteogenesis imperfecta.
- This surgical strategy may reduce the risk of fractures and other complications associated with sternotomy in OI patients.
- Further research into the long-term outcomes of MICS in OI patients is warranted to optimize treatment protocols.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...